Follow The Filings

APLE

Earnings company data as of 7:50 PM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS 0.43 — —
Rev — — —

Insider trades

Open-market buys and sales by APLE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All APLE insider trades
  • $165K bought by 3 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Glade M Knight Chair
    Buy
    $70K 5,000 shares at $13.97 +0.7% to stake
    Traded May 11 Filed May 13
    ↗
  2. Glade M Knight Chair
    Buy
    $60K 5,000 shares at $11.91 +0.7% to stake
    Traded Dec 11, 2025 Filed Dec 12, 2025
    ↗
  3. Redd Hugh Director
    Buy
    $12K 1,000 shares at $11.75 +0.7% to stake
    Traded Nov 13, 2025 Filed Nov 17, 2025
    ↗
  4. Howard E. Woolley Director
    Buy
    $24K 2,000 shares at $11.94 +6.9% to stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 38 stock grants, 14 share withholdings for taxes, 5 gifts, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
424B5 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,8.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07,8.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.